London - The Covid-19 vaccine candidate developed by Oxford University and Anglo-Swedish pharma AstraZeneca will continue its clinical trials in Brazil, despite the death of one of the volunteers, it was reported in London on Thursday.
According to Sky News television, which cited sources from the English university, an independent study of what happened found no reason to be concerned about the safety of the Brazilian trial.
AstraZeneca alleged that the company's policy does not allow to comment on individual events, but assured that in the case of the Brazilian volunteer, all investigation steps were followed. According to the press of that South American country, the volunteer would have received the placebo and not the Covid-19 vaccine.
UK clinical trials were put on hold for two weeks in September after one of the British volunteers developed dangerous side effects.
The Oxford vaccine, as it is now popularly known, is in Phase 3 clinical trial, the last before a vaccine is declared safe for mass vaccination. It is being tested in several countries, among them the United States, Brazil and India, the three hardest-hit countries by the pandemic.
Havana - Cuban President Miguel Díaz-Canel congratulated the emblematic Orquesta Aragón, winner of the 2020 Latin Grammy award in the category of Traditional Tropical Album.
On Twitter, the president celebrated the charanga's musical triumph, one of the nation's cultural ambassadors and flagship groups. The album Ícono, released by the Puntilla Music label, marked the group's 80th anniversary.Read More
Quito - The book 'Fidel, cuatro visitas a Ecuador' (Fidel, four visits to Ecuador), which collects details of the visits the historical leader of the Cuban Revolution, Fidel Castro, made to this South American country, will be launched this Wednesday in Quito.Read More
Havana - Cuban Foreign Minister Bruno Rodríguez congratulated on Tuesday the National Commission of the United Nations Educational, Scientific and Cultural Organization (UNESCO) on its 73rd anniversary.Read More